These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24402261)

  • 1. Projects set to tackle neglected diseases.
    Hayden EC
    Nature; 2014 Jan; 505(7482):142. PubMed ID: 24402261
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs for neglected diseases: part II.
    Kaneko T
    Future Med Chem; 2011 Sep; 3(11):1329-30. PubMed ID: 21879837
    [No Abstract]   [Full Text] [Related]  

  • 3. Neglected tropical disease research: rethinking the drug discovery model.
    Bombelles T; Coaker H
    Future Med Chem; 2015; 7(6):693-700. PubMed ID: 25996062
    [No Abstract]   [Full Text] [Related]  

  • 4. WHO plans for neglected diseases are wrong.
    Moran M
    Nature; 2014 Feb; 506(7488):267. PubMed ID: 24553204
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.
    Ioset JR; Chang S
    Future Med Chem; 2011 Sep; 3(11):1361-71. PubMed ID: 21879842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socio-economic aspects of neglected diseases: sleeping sickness and visceral leishmaniasis.
    Boelaert M; Meheus F; Robays J; Lutumba P
    Ann Trop Med Parasitol; 2010 Oct; 104(7):535-42. PubMed ID: 21092391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New models for pharmaceutical innovation in low-income countries.
    Ardal C; Iversen JH; Myhr K
    Tidsskr Nor Laegeforen; 2011 Oct; 131(20):2016-8. PubMed ID: 22016131
    [No Abstract]   [Full Text] [Related]  

  • 8. Hit and lead criteria in drug discovery for infectious diseases of the developing world.
    Katsuno K; Burrows JN; Duncan K; Hooft van Huijsduijnen R; Kaneko T; Kita K; Mowbray CE; Schmatz D; Warner P; Slingsby BT
    Nat Rev Drug Discov; 2015 Nov; 14(11):751-8. PubMed ID: 26435527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tropical disease: A neglected cause.
    Laursen L
    Nature; 2016 May; 533(7602):S68-9. PubMed ID: 27167396
    [No Abstract]   [Full Text] [Related]  

  • 10. Interview with Solomon Nwaka.
    Nwaka S
    Future Med Chem; 2011 Sep; 3(11):1339-44. PubMed ID: 21879840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Future of Drug Development for Neglected Tropical Diseases: How the European Commission Can Continue to Make a Difference.
    Pierce RJ; MacDougall J; Leurs R; Costi MP
    Trends Parasitol; 2017 Aug; 33(8):581-583. PubMed ID: 28529130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epilogue: New drugs for neglected diseases.
    Pogge T; Hollis A
    Camb Q Healthc Ethics; 2011 Apr; 20(2):329-34. PubMed ID: 21435308
    [No Abstract]   [Full Text] [Related]  

  • 13. More efficient ways of assessing treatments for neglected tropical diseases are required: innovative study designs, new endpoints, and markers of effects.
    Olliaro P; Vaillant MT; Sundar S; Balasegaram M
    PLoS Negl Trop Dis; 2012; 6(5):e1545. PubMed ID: 22666508
    [No Abstract]   [Full Text] [Related]  

  • 14. [An alternative and innovative Research and Development model to ensure access to medicines - Neglected diseases, neglected populations, and biomedical innovation system].
    Pécoul B
    Med Sci (Paris); 2016 Dec; 32(12):1049-1050. PubMed ID: 28044961
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug development partnerships look set to grow.
    Watts G
    Lancet; 2016 Jul; 388(10039):16-8. PubMed ID: 27397780
    [No Abstract]   [Full Text] [Related]  

  • 16. From bench to clinic: bridging the translational gap in neglected disease drug development.
    Ruminski PG
    Future Med Chem; 2011 Aug; 3(10):1253-7. PubMed ID: 21859300
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of patent sharing in neglected disease drug discovery.
    Edlin C
    Future Med Chem; 2011 Sep; 3(11):1331-4. PubMed ID: 21879838
    [No Abstract]   [Full Text] [Related]  

  • 18. Traditional drug-discovery model ripe for reform.
    Cressey D
    Nature; 2011 Mar; 471(7336):17-8. PubMed ID: 21368796
    [No Abstract]   [Full Text] [Related]  

  • 19. Global health: neglected diseases and access to medicines.
    Garg NJ
    Infect Dis Clin North Am; 2011 Sep; 25(3):639-51, ix-x. PubMed ID: 21896364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Talks restart on global initiative to fund research into diseases that affect poorer countries.
    Gulland A
    BMJ; 2013 Feb; 346():f702. PubMed ID: 23377793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.